A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
Yu Lin(University of Michigan–Ann Arbor), David M. Lubman(University of Michigan), Neehar D. Parikh(University of Michigan), Jie Zhang(University of Michigan), Zhijing Tan(University of Michigan), Jocelyn Olivares(The University of Texas Southwestern Medical Center), Amit G. Singal(Southwestern Medical Center), Lingyun Pan(University of Michigan), Jianhui Zhu(Qingdao University)
Cited by 34
Related Papers
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
|Nature Chemistry|2015|305
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177